December 28, 2014 5:21 PM ET

Pharmaceuticals

Company Overview of Ansun Biopharma, Inc.

Company Overview

Ansun Biopharma, Inc. manufactures and commercializes biopharmaceuticals to prevent and treat life-threatening human diseases. Its products include Fludase, a drug candidate for the prophylaxis and treatment of respiratory infections caused by various types of influenza virus, including the types of virus that may cause a potential influenza pandemic, as well as various types of parainfluenza virus. The company’s products also include Viradin, an intravenous therapeutic for sepsis and septic shock, as well as viral hemorrhagic fever caused by such pathogens as Ebola and Marburg viruses. In addition, its products include TOSAP, a formulation technology capable of creating microspheres and nan...

10665 Sorrento Valley Road

Suite 105

San Diego, CA 92121

United States

Founded in 2002

Phone:

858-452-2631

Fax:

858-452-2534

Key Executives for Ansun Biopharma, Inc.

Co-Founder
Age: 57
Co-Founder and President of Research & Development
Assistant Vice President of Finance & Administration
Executive Vice President of Clinical Development & Medical Affairs
Age: 53
Vice President of Corporate Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
PR Pharmaceuticals, Inc. United States
Osel Inc. United States
Oto Medicine Inc. United States
Flex Pharma, Inc. United States
GlaxoSmithKline Holdings (Americas) Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 13, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ansun Biopharma, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.